Efficacy and tolerability of first-line triple therapy with levofloxacin and amoxicillin plus esomeprazole or rabeprazole for the eradication of Helicobacter pylori infection and the effect of CYP 2C 19 genotype: a 1-week, randomized, open-label stud
Efficacy and tolerability of first-line triple therapy with levofloxacin and amoxicillin plus esomeprazole or rabeprazole for the eradication of Helicobacter pylori infection and the effect of CYP 2C 19 genotype: a 1-week, randomized, open-label stud
复制标题
左氧氟沙星和阿莫西林联合埃索美拉唑或雷贝拉唑一线三联疗法根除幽门螺杆菌感染的疗效和耐受性以及 CYP 2C 19 基因型的影响：一项为期 1 周、随机、开放标签的研究
DOI：
--
复制
发表时间：
--
期刊：
影响因子：
--
通讯作者：
Qian B
中科院分区：
文献类型：
--
作者：
Qiu Y;Li Y;Zhang G;Yao L;Shi R;Pan X;Tang Q;Qian B
